Citations (25)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Z. H. Israili & P. G. Dayton. (2001) HUMAN ALPHA-1-GLYCOPROTEIN AND ITS INTERACTIONS WITH DRUGS†,‡. Drug Metabolism Reviews 33:2, pages 161-235.
Read now
Read now
Articles from other publishers (24)
David A. Skaar, Randy L. Jirtle & Cathrine Hoyo. 2016. Epigenetics, Energy Balance, and Cancer. Epigenetics, Energy Balance, and Cancer
109
146
.
Darren R. Brenner, Dominique Scherer, Kenneth Muir, Joellen Schildkraut, Paolo Boffetta, Margaret R. Spitz, Loic Le Marchand, Andrew T. Chan, Ellen L. Goode, Cornelia M. Ulrich & Rayjean J. Hung. (2014) A Review of the Application of Inflammatory Biomarkers in Epidemiologic Cancer Research. Cancer Epidemiology, Biomarkers & Prevention 23:9, pages 1729-1751.
Crossref
Crossref
Gary G. Schwartz & Halcyon G. Skinner. (2012) A Prospective Study of Total and Ionized Serum Calcium and Time to Fatal Prostate Cancer. Cancer Epidemiology, Biomarkers & Prevention 21:10, pages 1768-1773.
Crossref
Crossref
Chang-Chi Chang, Alex T.L. Lin, Kuang-Kuo Chen, Hsiao-Jen Chung & Shyh-Chyi Chang. (2010) The Significance of Plasma C-reactive Protein in Patients With Elevated Serum Prostate-specific Antigen Levels. Urological Science 21:2, pages 88-92.
Crossref
Crossref
Junko Ishizaki, Akiko Fukaishi, Chie Fukuwa, Satoko Yamazaki, Mayu Tabata, Takuya Ishida, Yukio Suga, Kunizo Arai, Koichi Yokogawa & Ken-ichi Miyamoto. (2010) Evaluation of Selective Competitive Binding of Basic Drugs to .ALPHA.1-Acid Glycoprotein Variants. Biological and Pharmaceutical Bulletin 33:1, pages 95-99.
Crossref
Crossref
Brandon L. Pierce, Mary L. Biggs, Marvalyn DeCambre, Alexander P. Reiner, Christopher Li, Annette Fitzpatrick, Christopher S. Carlson, Janet L. Stanford & Melissa A. Austin. (2009) C-reactive protein, interleukin-6, and prostate cancer risk in men aged 65 years and older. Cancer Causes & Control 20:7, pages 1193-1203.
Crossref
Crossref
Peter A. McArdle, Khurram Mir, A.S.K. Almushatat, A. Michael Wallace, Mark A. Underwood & Donald C. McMillan. (2006) Systemic Inflammatory Response, Prostate-Specific Antigen and Survival in Patients with Metastatic Prostate Cancer. Urologia Internationalis 77:2, pages 127-129.
Crossref
Crossref
Steven Lehrer, Edward J. Diamond, Boris Mamkine, Michael J. Droller, Nelson N. Stone & Richard G. Stock. (2005) C-reactive protein is significantly associated with prostate-specific antigen and metastatic disease in prostate cancer. BJU International 95:7, pages 961-962.
Crossref
Crossref
Elizabeth A. Platz, Angelo M. De Marzo, Thomas P. Erlinger, Nader Rifai, Kala Visvanathan, Sandra C. Hoffman & Kathy J. Helzlsouer. (2003) No association between pre‐diagnostic plasma C‐reactive protein concentration and subsequent prostate cancer. The Prostate 59:4, pages 393-400.
Crossref
Crossref
ELIZABETH A. PLATZ & ANGELO M. De MARZO. (2004) Epidemiology of Inflammation and Prostate Cancer. Journal of Urology 171:2S.
Crossref
Crossref
DONALD C. McMILLAN, DINESH TALWAR, NAVEED SATTAR, MARK UNDERWOOD, DENIS ST J O'REILLY & COLIN McARDLE. (2002) The relationship between reduced vitamin antioxidant concentrations and the systemic inflammatory response in patients with common solid tumours. Clinical Nutrition 21:2, pages 161-164.
Crossref
Crossref
Z. Latif, D.C. McMillan, A.M. Wallace, N. Sattar, K. Mir, G. Jones & M.A. Underwood. (2002) The relationship of circulating insulin‐like growth factor 1, its binding protein‐3, prostate‐specific antigen and C‐reactive protein with disease stage in prostate cancer. BJU International 89:4, pages 396-399.
Crossref
Crossref
Joakim Göransson, Svante Jonsson & ke Lasson. (1996) Pre-operative plasma levels of C-reactive protein, albumin and various plasma protease inhibitors for the pre-operative assessment of operability and recurrence in cancer surgery. European Journal of Surgical Oncology (EJSO) 22:6, pages 607-617.
Crossref
Crossref
Edward H. Cooper, Mel R. G. Robinson, Peter Whelan & Micheal A. Ferro. (1992) Tumor markers in prostate cancer. Cancer 70:S1, pages 225-229.
Crossref
Crossref
J. K. SIDDALL, J. W. HETHERINGTON, E. H. COOPER, D. W. W. NEWLING, M. R. G. ROBINSON, B. RICHARDS & L. DENIS. (2008) Biochemical Monitoring of Carcinoma of Prostate Treated with an LH‐RH Analogue (Zoladex). British Journal of Urology 58:6, pages 676-682.
Crossref
Crossref
Sherif L. Rizk, Carolyn Mold, Michael Haklin & David L. Roseman. (1986) The role of C-reactive protein and polyarginine in tumor immunotherapy. Cancer 58:1, pages 55-61.
Crossref
Crossref
E.H. COOPER & M. BOWEN. 1984. Clinical Biochemistry. Clinical Biochemistry
1
53
.
I. Romics, J. Fehér & J. Horváth. (1983) Immunological studies of patients with tumours of the prostate and bladder. International Urology and Nephrology 15:4, pages 339-345.
Crossref
Crossref
M.B. Pepys & Marilyn L. Baltz. 1983. Advances in Immunology Volume 34. Advances in Immunology Volume 34
141
212
.
A. Akdas, E. H. Cooper, P. H. Smith & M. R. G. Robinson. 1983. Cancer of the Prostate and Kidney. Cancer of the Prostate and Kidney
125
131
.
M. R. G. Robinson, D. Daponte, A. Fryszman & C. Chandrasekaran. 1983. Cancer of the Prostate and Kidney. Cancer of the Prostate and Kidney
117
123
.
F.C. De Beer & M.B. Pepys. (1982) Solid-phase immunoradiometric assay for C-reactive protein using magnetisable cellulose particles. Journal of Immunological Methods 50:3, pages 299-308.
Crossref
Crossref
J. O'Quigley, Sarah Haworth, E.H. Cooper, W. Haije, B. Van der Werf-Messing, B. Richard & M.R.G. Robinson. (1981) Prognostic significance of serum proteins in invasive bladder cancer. European Journal of Cancer (1965) 17:2, pages 251-255.
Crossref
Crossref
Christine Wells, T.C. Bøjg-Hansen, E.H. Cooper & M.R. Glass. (1981) The use of concanavalin a crossed immuno-affinoelectrophoresis to detect hormone-associated variations in α1-acid glycoprotein. Clinica Chimica Acta 109:1, pages 59-67.
Crossref
Crossref